Market Tracker

06/28 10:10am ET

Apricus Biosciences Inc (NASDAQ:APRI)

1.06
Delayed Data
As of 9:53am ET
 -0.0264 / -2.42%
Today’s Change
0.86
Today|||52-Week Range
4.94
-18.18%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.09
Today’s open1.05
Day’s range1.04 - 1.06
Volume6,301
Average volume (3 months)448,578
Market cap$13.9M
Dividend yield--
Data as of 9:53am ET, 06/28/2017

Growth & Valuation

Earnings growth (last year)+70.20%
Earnings growth (this year)+117.95%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.09%
P/E ratioNM
Price/Sales1.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...-0.02-3.67%
EVARLombard Medical Inc+0.03+5.77%
EYEGEyeGate Pharmaceutic...-0.03-2.26%
KTOVKitov Pharmaceutical...+0.03+1.85%
Data as of 9:55am ET, 06/28/2017

Financials

Next reporting dateAugust 4, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$5.8M
Annual profit (last year)-$7.4M
Net profit margin-128.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts